Stock Events

Stock Events

UroGen Pharma (URGN) Q3 2023 Earnings

14NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-1.33

-1.11

-0.9

-0.68

Details

Expected EPS

-0.85

Actual EPS

-0.68

Surprise EPS

0.17

Surprise Percent

+20%

Description

UroGen Pharma (URGN) has reported earnings of -0.68 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.